If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Health Outcomes
Download FREE Excerpt
11 Info Graphics
12 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Development of strong HO capabilities within MA organizations requires increase in MA’s involvement with HO groups, development of field-based HO capabilities, customization of HO data according to stakeholders, and building real world data capabilities to generate and utilize HO information.
Best Practices, LLC undertook a study to help companies focused on oncology therapies find better ways to develop successful Health Outcomes groups. This research delivers current data and best practices from Medical Affairs leaders with an oncology focus at top biopharmaceutical companies.
This study engaged 10 executives from leading life sciences companies. The analysis is focused on companies with oncology therapies.
· Longevity of HO Groups: HO programs are common, but they represent a young initiative for many of the benchmark class; sixty percent of companies have had it in place for less than three years.
· Reporting Structure: 60% of companies’ HO groups report to Medical Affairs. A majority of the interviewed executives think that HO groups must report to a science and research oriented department such as clinical or medical affairs. Between these two, medical affairs provides better opportunities for needs assessment, communicating HO data insights, and interacting with key decision makers.
Table of Contents
§ Executive Summary pp. 3-9